These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 28377632)

  • 1. Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors.
    Ohshima K; Hatakeyama K; Nagashima T; Watanabe Y; Kanto K; Doi Y; Ide T; Shimoda Y; Tanabe T; Ohnami S; Ohnami S; Serizawa M; Maruyama K; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
    Sci Rep; 2017 Apr; 7(1):641. PubMed ID: 28377632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of druggable cancer driver genes amplified across TCGA datasets.
    Chen Y; McGee J; Chen X; Doman TN; Gong X; Zhang Y; Hamm N; Ma X; Higgs RE; Bhagwat SV; Buchanan S; Peng SB; Staschke KA; Yadav V; Yue Y; Kouros-Mehr H
    PLoS One; 2014; 9(5):e98293. PubMed ID: 24874471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
    Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
    Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
    Fields AP; Justilien V; Murray NR
    Adv Biol Regul; 2016 Jan; 60():47-63. PubMed ID: 26754874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
    Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
    Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
    Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
    Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated analysis of cancer genes in clear cell renal cell carcinoma.
    Li J; Guo L; Ai Z
    Future Oncol; 2017 Apr; 13(8):715-725. PubMed ID: 28266251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma.
    Fouret R; Laffaire J; Hofman P; Beau-Faller M; Mazieres J; Validire P; Girard P; Camilleri-Bröet S; Vaylet F; Leroy-Ladurie F; Soria JC; Fouret P
    Clin Cancer Res; 2012 Oct; 18(20):5606-16. PubMed ID: 22914773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovering potential cancer driver genes by an integrated network-based approach.
    Shi K; Gao L; Wang B
    Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients.
    Suo C; Deng W; Vu TN; Li M; Shi L; Pawitan Y
    Biol Direct; 2018 Jul; 13(1):14. PubMed ID: 30012197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
    Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
    Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.
    Park H; Niida A; Imoto S; Miyano S
    J Comput Biol; 2017 Feb; 24(2):138-152. PubMed ID: 27759426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
    Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
    PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis.
    Li CF; Chen LT; Lan J; Chou FF; Lin CY; Chen YY; Chen TJ; Li SH; Yu SC; Fang FM; Tai HC; Huang HY
    Oncotarget; 2014 Nov; 5(22):11588-603. PubMed ID: 25473890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
    Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
    BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crucial and novel cancer drivers in a mouse model of triple-negative breast cancer.
    Johnson JP; Kumar P; Koulnis M; Patel M; Simin K
    Cancer Genomics Proteomics; 2014; 11(3):115-26. PubMed ID: 24969692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
    Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
    Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.